Priser
Platform
Blog
Om os
Download
Biotalys
Biotalys
Euronext Brussels
0

Om

Biotalys NV is an agricultural technology company developing protein-based biocontrol solutions for sustainable crop protection. The company specializes in biofungicides and bioinsecticides that target pests and pathogens such as botrytis, powdery mildew, anthracnose, leafspot diseases, oomycetes, and alternaria in fruits, vegetables, legumes, and specialty crops. Its proprietary AGROBODY Foundry technology platform generates these innovative protein-based products, offering precise alternatives to conventional chemical pesticides while minimizing environmental impact and ensuring safety for farmers and consumers. Biotalys NV advances a pipeline including EVOCA for first-generation and next-generation biofungicides, BIOFUN-6, BIOFUN-7, BIOFUN-4, BIOFUN-8, and BioIns-2 against key insect pests. These solutions address crop protection from soil to post-harvest, aiming to reduce food waste and improve yield quality across the food value chain. Founded in 2013 and headquartered in Ghent, Belgium, Biotalys NV plays a pivotal role in the AgTech sector by pioneering precision biocontrols for safer food production.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BIOTALYS MED ENDAVU: Køb Biotalys ($BTLS) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Biotalys, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerBTLS
Land
Belgien
Antal medarbejdere62
Hjemmesidebiotalys.com
SektorRåstoffer
IndustriLandbrugsinput

Analytikerskøn

Baseret på 2 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%100%0%0%0%